AI assistant
Alector, Inc. — Director's Dealing 2019
Nov 19, 2019
33290_dirs_2019-11-19_3a466acf-42ba-41fa-950c-d5be76ddc4dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alector, Inc. (ALEC)
CIK: 0001653087
Period of Report: 2019-11-15
Reporting Person: Paul Robert (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-15 | Common Stock | S | 10000 | $15.93 | Disposed | 293719 | Direct |
Footnotes
F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $15.47 to $16.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3: The shares reported in Column 5 of Table I reflect the adjustments reported in the Reporting Person's Form 4/A filed on November 19, 2019.